Tissue engineering: A new frontier in physiological genomics

Physiological Genomics

Volumn 32, Issue 1, 2007, Pages 28-32

  Petersen, Matthew C ^a   Lazar, Jozef ^a   Jacob, Howard J ^a   Wakatsuki, Tetsuro ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Engineered tissue; Gene function; Three dimensional cell culture

Indexed keywords

SMALL INTERFERING RNA;

CELL ADHESION; CELL CULTURE; CELL ISOLATION; CELL SURVIVAL; FIBROBLAST; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENETIC SCREENING; GENETIC TRANSFECTION; GENOMICS; HEART; HIGH THROUGHPUT SCREENING; HUMAN; IN VIVO STUDY; MOLECULAR GENETICS; MUSCLE CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; THREE DIMENSIONAL IMAGING; TISSUE ENGINEERING; TISSUE STRUCTURE;

ANIMALS; CELL CULTURE TECHNIQUES; GENOMICS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; TISSUE ENGINEERING;

EID: 37449018943     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00165.2007     Document Type: Review

References (38)

1. Improved Standards for Laboratory Animals Act. 1985.
2. Asnes CF, Marquez JP, Elson EL, Wakatsuki T. Reconstitution of the Frank-Starling mechanism in engineered heart tissues. Biophys J 91: 1800-1810, 2006.
3. Baker JE, Konorev EA, Gross GJ, Chilian WM, Jacob HJ. Resistance to myocardial ischemia in five rat strains: is there a genetic component of cardioprotection? Am J Physiol Heart Circ Physiol 278: H1395-H1400, 2000.
4. Birgersdotter A, Sandberg R, Ernberg I. Gene expression perturbation in vitro - a growing case for three-dimensional (3D) culture systems. Semin Cancer Biol 15: 405-412, 2005.
5. Bosch TM, Meijerman I, Beijnen JH, Schellens JH. Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer. Clin Pharmacokinet 45: 253-285, 2006.
6. Chalfoun CT, Wirth GA, Evans GR. Tissue engineered nerve constructs: where do we stand? J Cell Mol Med 10: 309-317, 2006.
7. Cowley AW. Physiological genomics: tools and concepts. J Physiol 554: 3, 2004.
8. Cowley AW Jr, Liang M, Roman RJ, Greene AS, Jacob HJ. Consomic rat model systems for physiological genomics. Acta Physiol Scand 181: 585-592, 2004.
9. Cukierman E, Pankov R, Stevens DR, Yamada KM. Taking cell-matrix adhesions to the third dimension. Science 294: 1708-1712, 2001.
10. Daly AK. Individualized drug therapy. Curr Opin Drug Discov Devel 10: 29-36, 2007.
11. Delbridge LM, Roos KP. Optical methods to evaluate the contractile function of unloaded isolated cardiac myocytes. J Mol Cell Cardiol 29: 11-25, 1997.
12. Elkayam T, Amitay-Shaprut S, Dvir-Ginzberg M, Harel T, Cohen S. Enhancing the drug metabolism activities of C3A - a human hepatocyte cell line - by tissue engineering within alginate scaffolds. Tissue Eng 12: 1357-1368, 2006.
13. Freed LE, Guilak F, Guo XE, Gray ML, Tranquillo R, Holmes JW, Radisic M, Sefton MV, Kaplan D, Vunjak-Novakovic G. Advanced tools for tissue engineering: scaffolds, bioreactors, and signaling. Tissue Eng 12: 3285-3305, 2006.
14. Ghosh S, Spagnoli GC, Martin I, Ploegert S, Demougin P, Heberer M, Reschner A. Three-dimensional culture of melanoma cells profoundly affects gene expression profile: a high density oligonucleotide array study. J Cell Physiol 204: 522-531, 2005.
15. Gurtner GC, Callaghan MJ, Longaker MT. Progress and potential for regenerative medicine. Annu Rev Med 58: 299-312, 2007.
16. Heyde M, Partridge KA, Oreffo RO, Howdle SM, Shakesheff KM, Garnett MC. Gene therapy used for tissue engineering applications. J Pharm Pharmacol 59: 329-350, 2007.
17. Huby T, Afzal V, Doucet C, Lawn RM, Gong EL, Chapman MJ, Thillet J, Rubin EM. Regulation of the expression of the apolipoprotein(a) gene: evidence for a regulatory role of the 5′ distal apolipoprotein(a) transcription control region enhancer in yeast artificial chromosome transgenic mice. Arterioscler Thromb Vasc Biol 23: 1633-1639, 2003.
18. Humes HD. Stem cells: the next therapeutic frontier. Trans Am Clin Climatol Assoc 116: 167-183, 2005.
19. L'Heureux N, Dusserre N, Konig G, Victor B, Keire P, Wight TN, Chronos NA, Kyles AE, Gregory CR, Hoyt G, Robbins RC, McAllister TN. Human tissue-engineered blood vessels for adult arterial revascularization. Nat Med 12: 361-365, 2006.
20. Li S, Lao J, Chen BP, Li YS, Zhao Y, Chu J, Chen KD, Tsou TC, Peck K, Chien S. Genomic analysis of smooth muscle cells in 3-dimensional collagen matrix. FASEB J 17: 97-99, 2003.
21. Liu H, Fan H, Cui Y, Chen Y, Yao K, Goh JC. Effects of the controlled-released basic fibroblast growth factor from chitosan-gelatin microspheres on human fibroblasts cultured on a chitosan-gelatin scaffold. Biomacromolecules 8: 1446-1455, 2007.
22. Liu Z, Greco AJ, Hellman NE, Spector J, Robinson J, Tang OT, Lipschutz JH. Intracellular signaling via ERK/MAPK completes the pathway for tubulogenic fibronectin in MDCK cells. Biochem Biophys Res Commun 353: 793-798, 2007.
23. Mikos AG, Herring SW, Ochareon P, Elisseeff J, Lu HH, Kandel R, Schoen FJ, Toner M, Mooney D, Atala A, Van Dyke ME, Kaplan D, Vunjak-Novakovic G. Engineering complex tissues. Tissue Eng 12: 3307-3339, 2006.
24. Naito H, Melnychenko I, Didie M, Schneiderbanger K, Schubert P, Rosenkranz S, Eschenhagen T, Zimmermann WH. Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle. Circulation 114: I72-I78, 2006.
25. Nho RS, Xia H, Diebold D, Kahm J, Kleidon J, White E, Henke CA. PTEN regulates fibroblast elimination during collagen matrix contraction. J Biol Chem 281: 33291-33301, 2006.
26. Petropavlovskaia M, Makhlin J, Sampalis J, Rosenberg L. Development of an in vitro pancreatic tissue model to study regulation of islet neogenesis associated protein expression. J Endocrinol 191: 65-81, 2006.
27. Remppis A, Pleger ST, Most P, Lindenkamp J, Ehlermann P, Schweda C, Loffler E, Weichenhan D, Zimmermann W, Eschenhagen T, Koch WJ, Katus HA. S100A1 gene transfer: a strategy to strengthen engineered cardiac grafts. J Gene Med 6: 387-394, 2004.
28. Ringe J, Haupl T, Sittinger M. Future of tissue engineering in rheumatic diseases. Expert Opin Biol Ther 7: 283-287, 2007.
29. Sawaguchi N, Majima T, Iwasaki N, Funakoshi T, Shimode K, Onodera T, Minami A. Extracellular matrix modulates expression of cell-surface proteoglycan genes in fibroblasts. Connect Tissue Res 47: 141-148, 2006.
30. Serrano MC, Pagani R, Manzano M, Comas JV, Portoles MT. Mitochondrial membrane potential and reactive oxygen species content of endothelial and smooth muscle cells cultured on poly(epsilon-caprolactone) films. Biomaterials 27: 4706-4714, 2006.
31. Smiley AK, Klingenberg JM, Aronow BJ, Boyce ST, Kitzmiller WJ, Supp DM. Microarray analysis of gene expression in cultured skin substitutes compared with native human skin. J Invest Dermatol 125: 1286-1301, 2005.
32. Solomon NA, Pranav SK, Jain KA, Kumar M, Kulkarni CB, Akbari J. In search of a pediatric cardiac surgeon's 'Holy Grail': the ideal pulmonary conduit. Expert Rev Cardiovasc Ther 4: 861-870, 2006.
33. Stegemann JP, Hong H, Nerem RM. Mechanical, biochemical, and extracellular matrix effects on vascular smooth muscle cell phenotype. J Appl Physiol 98: 2321-2327, 2005.
34. Uebersax L, Hagenmuller H, Hofmann S, Gruenblatt E, Muller R, Vunjaknovakovic G, Kaplan DL, Merkle HP, Meinel L. Effect of scaffold design on bone morphology in vitro. Tissue Eng 2: 3417-3429, 2006.
35. Wang F, Weaver VM, Petersen OW, Larabell CA, Dedhar S, Briand P, Lupu R, Bissell MJ. Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. Proc Natl Acad Sci USA 95: 14821-14826, 1998.
36. Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, Damsky C, Bissell MJ. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 137: 231-245, 1997.
37. Zahir N, Weaver VM. Death in the third dimension: apoptosis regulation and tissue architecture. Curr Opin Genet Dev 14: 71-80, 2004.
38. Zimmermann WH, Didie M, Doker S, Melnychenko I, Naito H, Rogge C, Tiburcy M, Eschenhagen T. Heart muscle engineering: an update on cardiac muscle replacement therapy. Cardiovasc Res 71: 419-429, 2006.